Numinus Wellness Announces Expansion To Research Lab

Numinus Wellness (TSXV: NUMI) has expansion on its mind. The company this morning announced that it plans to expand its psychedelics research lab by the end of 2021.

The expansion, slated to be 7,500 square feet in size, is expected to take place in an existing building that is being leased by the company. The expansion is to be “developed and housed” in the building adjacent to the current lab.

The expansion is part of the firms IP and partnerships strategy, which will reportedly enable higher revenue generation through analytical testing for psychedelics and other services, while increasing the supply of psychedelics for clinical use and trials. The expansion is also expected to add several psychedelic substances and capabilities to current contract lab services, increase capacity for testing, and enhance the firms current R&D program.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Numinus has also reportedly spent $1.2 million on new equipment for the current facility to enhance current research to optimize the cultivation, harvest and extraction of psilocybe mushrooms, as well as to “implement discovery of unknowns and interactions in several psychedelic botanicals.”

An estimated cost of the expansion was not provided by the company.

Numinus Wellness last traded at $1.33 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Numinus Wellness Sells Off Shares In Alto Neuroscience Ahead Of IPO

Numinus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in...

Thursday, February 1, 2024, 09:28:12 AM

Numinus Wellness To Collaborate With MAPS On Proposed MDMA-Assisted Psychotherapy Trials

Numinus Wellness (TSXV: NUMI) this morning announced that it has entered into an arrangement with...

Wednesday, December 2, 2020, 08:28:51 AM

Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing

After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally...

Tuesday, December 29, 2020, 04:49:21 PM

Numinus Wellness To Acquire Mindspace Psychology Services Of Montreal

Numinus Wellness (TSXV: NUMI) is acquiring that of Mindspace Psychology Services, whom operates as Mindspace...

Tuesday, December 15, 2020, 08:34:20 AM

Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round

Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that...

Friday, February 2, 2024, 09:00:02 AM